1
Participants
Start Date
October 31, 2012
Primary Completion Date
November 30, 2012
Study Completion Date
November 30, 2012
Mexiletine
6-day treatment period during which the medication will be taken orally with an initial dose of: 200 mg every 8 hours for 3 doses on day 3, increasing to 300 mg every 8 hours on days 4 and 5 (6 doses), and increasing further to 400 mg every 8 hours on days 6-8 if no telemetry changes and no dose limiting side effects
Lead Sponsor
Mayo Clinic
OTHER